HCV NS3 protease inhibitors
Details for Australian Patent Application No. 2007309544 (hide)
International Classifications
Event Publications
21 May 2009 PCT application entered the National Phase
PCT publication WO2008/051475 Priority application(s): WO2008/051475
21 January 2010 Alteration of Name
The name of the applicant has been altered to Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.; Merck Sharp & Dohme Corp.
31 May 2012 Application Accepted
Published as AU-B-2007309544
27 September 2012 Alteration of Name
The name of the patentee has been altered to Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.; Merck Sharp & Dohme Corp. 2008
27 September 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007309546-HCV NS3 protease inhibitors
2007309535-Method and apparatus for sending a channel quality indication via a shared channel
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser